These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 10933393)

  • 1. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities.
    Xu JL; Davis MM
    Immunity; 2000 Jul; 13(1):37-45. PubMed ID: 10933393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic diversity of the immunoglobulin repertoire is controlled in an isotype-specific manner.
    Luger E; Lamers M; Achatz-Straussberger G; Geisberger R; Inführ D; Breitenbach M; Crameri R; Achatz G
    Eur J Immunol; 2001 Aug; 31(8):2319-30. PubMed ID: 11477544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The J558 VH CDR3 region contributes little to antibody avidity; however, it is the recognition element for cognate T cell control of the alpha(1-->3) dextran-specific antibody response.
    Clemens A; Rademaekers A; Specht C; Kölsch E
    Int Immunol; 1998 Dec; 10(12):1931-42. PubMed ID: 9885915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rearrangement of the human heavy chain variable region gene V3-23 in transgenic mice generates antibodies reactive with a range of antigens on the basis of VHCDR3 and residues intrinsic to the heavy chain variable region.
    Mageed RA; Harmer IJ; Wynn SL; Moyes SP; Maziak BB; Brüggemann M; MacKworth-Young CG
    Clin Exp Immunol; 2001 Jan; 123(1):1-8. PubMed ID: 11167990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA.
    Li Z; Schettino EW; Padlan EA; Ikematsu H; Casali P
    Eur J Immunol; 2000 Jul; 30(7):2015-26. PubMed ID: 10940891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1,3galactosyltransferase knock out mice.
    Chen ZC; Radic MZ; Galili U
    Mol Immunol; 2000 Jun; 37(8):455-66. PubMed ID: 11090880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and construction of a hybrid immunoglobulin domain with properties of both heavy and light chain variable regions.
    Ill CR; Gonzales JN; Houtz EK; Ludwig JR; Melcher ED; Hale JE; Pourmand R; Keivens VM; Myers L; Beidler K; Stuart P; Cheng S; Radhakrishnan R
    Protein Eng; 1997 Aug; 10(8):949-57. PubMed ID: 9415445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
    Ichiyoshi Y; Casali P
    J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral recognition of a dye hapten by a llama VHH domain.
    Spinelli S; Tegoni M; Frenken L; van Vliet C; Cambillau C
    J Mol Biol; 2001 Aug; 311(1):123-9. PubMed ID: 11469862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
    Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
    J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and validation of a synthetic VH repertoire with tailored diversity for protein recognition.
    Almagro JC; Quintero-Hernández V; Ortiz-León M; Velandia A; Smith SL; Becerril B
    J Mol Recognit; 2006; 19(5):413-22. PubMed ID: 16881059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodies.
    Mertens NM; Galvin JE; Adderson EE; Cunningham MW
    Mol Immunol; 2000 Oct; 37(15):901-13. PubMed ID: 11282394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of monovalent fragments derived from a human IgM autoantibody in E. coli. The input of the somatically mutated CDR1/CDR2 and of the CDR3 into antigen binding specificity.
    Jahn S; Roggenbuck D; Niemann B; Ward ES
    Immunobiology; 1995 Aug; 193(5):400-19. PubMed ID: 8522357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine IgM antibodies with exceptionally long complementarity-determining region 3 of the heavy chain share unique structural properties conferring restricted VH + Vlambda pairings.
    Saini SS; Farrugia W; Ramsland PA; Kaushik AK
    Int Immunol; 2003 Jul; 15(7):845-53. PubMed ID: 12807823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restricted CDR3 length of the heavy chain is characteristic of six randomly isolated disease-associated VH J558+ IgM autoantibodies in lupus prone motheaten mice.
    Lipsanen V; Walter B; Emara M; Siminovitch K; Lam J; Kaushik A
    Int Immunol; 1997 May; 9(5):655-64. PubMed ID: 9184911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and affinity studies of IgM polyreactive natural autoantibodies.
    Diaw L; Magnac C; Pritsch O; Buckle M; Alzari PM; Dighiero G
    J Immunol; 1997 Jan; 158(2):968-76. PubMed ID: 8993018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Light and heavy chains specifying a human IgM kappa autoantibody to a T-cell receptor V beta-antigen.
    Dedeoglu F; Kaymaz H; Klein G; Marchalonis JJ
    Immunol Lett; 1993 Nov; 38(3):223-7. PubMed ID: 8125530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
    Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
    Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.